BK vs GYRE · P/E 17, $94.14B cap vs rev $53.5M
The Bank of New York Mellon Corporation (BK) versus Gyre Therapeutics Inc. (GYRE) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
BK does not have a complete income-statement cache yet.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. GYRE currently screens at market cap $589.9M.
Not investment advice. Open the BK and GYRE stock pages for the full models.
Not investment advice.